Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 30;28(4):203-207.
doi: 10.4103/meajo.MEAJO_324_19. eCollection 2021 Oct-Dec.

Platelet Activation in Ocular Behçet's Patients with Posterior Segment Involvement

Mehmet Citirik  1 , Pinar C Ozdal  1 , Ali Keles  2 , Ibrahim C Haznedaroglu  3
Affiliations

Platelet Activation in Ocular Behçet's Patients with Posterior Segment Involvement

Mehmet Citirik et al. Middle East Afr J Ophthalmol. .

Abstract

Purpose: The aim of the present study was to assess platelet activation by analyzing three platelet activation parameters in ocular Behçet's disease (BD): mean platelet volume (MPV), platelet distribution width (PDW), and plateletcrit (PCT).

Methods: Twenty-nine patients with active ocular BD (Group 1), 40 patients with inactive ocular BD (Group 2), and 40 healthy adult individuals serving as controls (Group 3) were evaluated. All of the individuals had been performed the complete ophthalmologic evaluation. The levels of MPV, PDW, and PCT were measured in each group.

Results: The mean MPV level was 8.40 ± 0.97 in Group 1, 8.32 ± 1.04 in Group 2, and 7.77 ± 0.72 in Group 3. The mean PDW level was 15.12 ± 1.09 in Group 1, 14.97 ± 1.02 in Group 2, and 14.52 ± 0.82 in Group 3. The mean PCT level was 0.23 ± 0.07 in Group 1, 0.21 ± 0.04 in Group 2, and 0.18 ± 0.03 in Group 3. MPV, PDW, and PCT levels were significantly higher in ocular BD patients than controls (P < 0.05).

Conclusion: Platelet activation may affect vascular occlusion in ocular Behçet's patients with posterior segment involvement. This result may be important in evaluating ocular BD patients.

Keywords: Behçet's disease; mean platelet volume; ocular involvement; platelet distribution width; plateletcrit.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

References

    1. Verity DH, Wallace GR, Vaughan RW, Stanford MR. Behçet's disease: From Hippocrates to the third millennium. Br J Ophthalmol. 2003;87:1175–83. - PMC - PubMed
    1. Dündar S, Ünal S, Sivri B, Muderrisodglu H, Kansu E, Karacadag S, et al. Behçet’s disease in Turkish population: Analysis of 200 cases. In: Lehner T, Barnes C, editors. Recent Advances in Behçet’s Disease. London: Royal Society of Medicine Services; 1986. pp. 219–21.
    1. Hazleman BL. Rheumatic disorders of the eye and the various structures involved. Br J Rheumatol. 1996;35:258–68. - PubMed
    1. Ozdal PC, Ortaç S, Taşkintuna I, Firat E. Posterior segment involvement in ocular Behçet's disease. Eur J Ophthalmol. 2002;12:424–31. - PubMed
    1. Stübiger N, Zierhut M, Kötter I. Ocular manifestations in Behçet’s disease. In: Zierhut M, Ohno S, editors. Immunology of Behçet’s Disease. Lisse, Netherlands: Swets, Zeitlinger; 2003. pp. 36–45.